The negative regulation of toll-like receptor and associated pathways

被引:110
作者
Lang, Tali [1 ]
Mansell, Ashley [1 ]
机构
[1] Monash Univ, Monash Inst Med Res, Ctr Funct Genom & Human Dis, Melbourne, Vic 3168, Australia
关键词
toll-like receptors; negative regulation; NF-kappa B; signal transduction;
D O I
10.1038/sj.icb.7100094
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Toll-like receptors (TLRs) are essential mediators of both innate and adaptive immunity by recognizing and eliciting responses upon invasion of pathogens. The response of TLRs must be stringently regulated as exaggerated expression of signalling components as well as pro-inflammatory cytokines can have devastating effects on the host, resulting in chronic inflammatory diseases, autoimmune disorders and aid in the pathogenesis of TLR-associated human diseases. Therefore, it is essential that negative regulators act at multiple levels within TLR signalling cascades, as well as through eliciting negative-feedback mechanisms in order to synchronize the positive activation and negative regulation of signal transduction to avert potentially harmful immunological consequences. This review explores the various mechanisms employed by negative regulators to ensure the appropriate modulation of both immune and inflammatory responses.
引用
收藏
页码:425 / 434
页数:10
相关论文
共 126 条
  • [31] A new protein containing an SH2 domain that inhibits JAK kinases
    Endo, TA
    Masuhara, M
    Yokouchi, M
    Suzuki, R
    Sakamoto, H
    Mitsui, K
    Matsumoto, A
    Tanimura, S
    Ohtsubo, M
    Misawa, H
    Miyazaki, T
    Leonor, N
    Taniguchi, T
    Fujita, T
    Kanakura, Y
    Komiya, S
    Yoshimura, A
    [J]. NATURE, 1997, 387 (6636) : 921 - 924
  • [32] β-Arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression
    Fan, Hongkuan
    Luttrell, Louis M.
    Tempel, George E.
    Senn, Joseph J.
    Halushka, Perry V.
    Cook, James A.
    [J]. MOLECULAR IMMUNOLOGY, 2007, 44 (12) : 3092 - 3099
  • [33] Triad3A regulates ubiquitination and proteasomal degradation of RIP1 following disruption of Hsp90 binding
    Fearns, Colleen
    Pan, Qilin
    Mathison, John C.
    Chuang, Tsung-Hsien
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (45) : 34592 - 34600
  • [34] Regulation of mammalian defensin expression by Toll-like receptor-dependent and independent signalling pathways
    Froy, O
    [J]. CELLULAR MICROBIOLOGY, 2005, 7 (10) : 1387 - 1397
  • [35] PI3K and negative regulation of TLR signaling
    Fukao, T
    Koyasu, S
    [J]. TRENDS IN IMMUNOLOGY, 2003, 24 (07) : 358 - 363
  • [36] Identification of β-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-κB pathways
    Gao, H
    Sun, Y
    Wu, YL
    Luan, B
    Wang, YY
    Qu, B
    Pei, G
    [J]. MOLECULAR CELL, 2004, 14 (03) : 303 - 317
  • [37] Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family
    Garlanda, C
    Riva, F
    Polentarutti, N
    Buracchi, C
    Sironi, M
    De Bortoli, M
    Muzio, M
    Bergottini, R
    Scanziani, E
    Vecchi, A
    Hirsch, E
    Mantovani, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (10) : 3522 - 3526
  • [38] Pathogens target DC-SIGN to influence their fate - DC-SIGN functions as a pathogen receptor with broad specificity
    Geijtenbeek, TBH
    van Kooyk, Y
    [J]. APMIS, 2003, 111 (7-8) : 698 - 714
  • [39] Mycobacteria target DC-SIGN to suppress dendritic cell function
    Geijtenbeek, TBH
    van Vliet, SJ
    Koppel, EA
    Sanchez-Hernandez, M
    Vandenbroucke-Grauls, CMJE
    Appelmelk, B
    van Kooyk, Y
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (01) : 7 - 17
  • [40] Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses
    Geijtenbeek, TBH
    Torensma, R
    van Vliet, SJ
    van Duijnhoven, GCF
    Adema, GJ
    van Kooyk, Y
    Figdor, CG
    [J]. CELL, 2000, 100 (05) : 575 - 585